Cialis

Phase 2Small molecule

Pfizer

Cialis is one of 87 small molecule programs targeting Erectile Dysfunction. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Erectile DysfunctionActive, not recruiting

Sexual DysfunctionActive, not recruiting

InfluenzaActive, not recruiting

Erectile DysfunctionPhase 2

Active, not recruiting

Sexual DysfunctionPhase 2

Active, not recruiting

InfluenzaPhase 1

Active, not recruiting

Competition

Competitive Landscape

1053 competitors in Influenza

#DrugCompanyPhaseTrials

Fluzone

GSK

Preclinical

37 2

Crestor

AstraZeneca

Preclinical

1 3

Trexall

Alnylam Pharmaceuticals

Preclinical

1 4

Cialis

Pfizer

Phase 2

1 5

Avigan

AAppili Therapeutics Inc.

Preclinical

6 6

Quadrivalent Influenza Vaccine

Sanofi

Preclinical

30 7

COMIRNATY

Pfizer

Preclinical

1 8

Focetria

CChiltern Pesquisa Clinica Ltda

Preclinical

1 9

Antihistamine

Arrowhead Pharmaceuticals

Preclinical

1 10

Influenza A/H5N1

NNational Institute of Allergy and Infectious Diseases (NIAID)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Erectile Dysfunction2 trials

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

Completed· Pfizer logo

Pfizer·Phase 2·NCT00174486·300 enrolled

Safety and Efficacy of YHD1023 in Erectile Dysfunction

Completed·YYuhan Corporation·Phase 2·NCT01423370·104 enrolled

Influenza1 trial

Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy

Completed·OOttawa Hospital Research Institute·Phase 1·NCT02998736·28 enrolled

Tics1 trial

Safety and Pharmacokinetic Characteristics of DKF-313

Completed·DDongkook Pharmaceutical Co., Ltd.·Phase 1·NCT02352311·54 enrolled

Trial1 trial

Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment

Completed·UUniversity of California, Irvine·Phase 4·NCT03229889·220 enrolled

Sexual Dysfunction1 trial

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Completed·UUniversity of Medicine and Dentistry of New Jersey·Phase 2·NCT00707187·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Cialis. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cialis compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cialis. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: Pfizer

Cialis

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Erectile Dysfunction2 trials

Influenza1 trial

Tics1 trial

Trial1 trial

Sexual Dysfunction1 trial

References

Drug Info

Quick Facts

Related News